GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings (GDRX) reported Non-Current Deferred Tax Liability of $650000.0 for Q3 2022, up 42.86% sequentially from $455000.0 in Q2 2022.

GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends

GoodRx Holdings (GDRX) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $650000.0 in Q3 2022.

For the quarter ending Q3 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $650000.0; the trailing twelve-month figure through Sep 2022 stood at $650000.0 (changed N/A YoY), and the FY2021 full-year result was $244000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability advanced to $650000.0 in Q3 2022, from $455000.0 in the prior quarter.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q3 2020 to a low of $244000.0 in Q4 2021.
A 3-year average of $703600.0 and a median of $455000.0 in 2022 frame the typical range for Non-Current Deferred Tax Liability.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	31.68 Bn	24.36 Bn	662.02 Mn
2	BrightSpring Health Services	14.66 Bn	13.76 Bn	482.22 Mn
3	Healthequity	8.28 Bn	8.02 Bn	256.31 Mn
4	Hinge Health	5.88 Bn	5.56 Bn	154.23 Mn
5	10x Genomics	5.81 Bn	5.27 Bn	106.18 Mn
6	MiniMed	4.51 Bn	4.21 Bn	480.00 Mn
7	Waystar Holding	4.45 Bn	4.39 Bn	216.84 Mn
8	Doximity	3.94 Bn	3.19 Bn	125.97 Mn
9	Privia Health	3.17 Bn	2.75 Bn	-
10	GoodRx Holdings	1.02 Bn	784.18 Mn	173.85 Mn

Download Data